José Manuel Otero

José Manuel (Manny) Otero is an accomplished professional in the biotech and biopharma sectors, currently serving as a Board Member at Cellipont Bioservices and Chief Technical Officer at Lexeo Therapeutics. With extensive experience in various leadership roles, including Chief Technology Officer at Turnstone Biologics and Vice President at Seres Therapeutics, Manny has significantly advanced bioprocess development and manufacturing strategies for innovative therapies. An elected member of the Connecticut Academy of Science and Engineering, Manny's educational background includes a PhD in Chemical and Biological Engineering from Chalmers University of Technology and a combined BS and MEng in Chemical Engineering and Biomedical Engineering from the Massachusetts Institute of Technology.